Hematologic Cancers Resource Center

Viewpoints

Idelalisib Plus Rituximab Highly Effective for Relapsed CLL

Idelalisib Plus Rituximab Highly Effective for Relapsed CLL

Resistance to initial therapy for patients with CLL may limit treatment options; however, rituximab combined with the PI3K inhibitor idelalisib may offer a tolerable alternative therapy.

A "Game Changer" in ALL and CLL?

A "Game Changer" in ALL and CLL?

"Serial killer" T cells produce sustained responses in patients with leukemia.

Feature Articles

Strategies to Overcome TKI Resistance in CML: Autophagy Inhibition

Strategies to Overcome TKI Resistance in CML: Autophagy Inhibition

Autophagy inhibition may prove to be a valuable tool for overcoming TKI resistance when treating chronic myeloid leukemia.

Hematologic Cancers Resources

More Hematologic Cancers Information

Understanding Follicular Lymphoma

Review information on the diagnosis, treatment, and management of follicular lymphoma.

Adherence and CML: Overcome the Challenges to Taking Your Pills

This fact sheet offers tips to help patients with chronic myelogenous leukemia overcome challenges to adhering to treatment regimens.

Managing Practical Concerns Raised by CML

Patients with CML may need help sorting through treatment options, managing side effects, and finding financial aid. This fact sheet is designed to offer support in these areas.

Treatments for Chronic Myelogenous Leukemia

This fact sheet educates patients about what causes chronic myelogenous leukemia (CML) and how it can be treated.

Medical Updates on Myelofibrosis

This fact sheet explains myelofibrosis, treatment options, and quality of life issues to help patients and their loved ones cope with a diagnosis.

Case Study: What's Causing this Linear Rash in a Patient with Hodgkin Lymphoma?

Case Study: What's Causing this Linear Rash in a Patient with Hodgkin Lymphoma?

A 23-year-old patient with Hodgkin lymphoma was seen as an inpatient consultation for a pruritic rash that had been present ...

A 47-Year-Old Woman with Pancytopenia After Treatment with Radioiodine Therapy

A 47-Year-Old Woman with Pancytopenia After Treatment with Radioiodine Therapy

By Justin M. Watts, MD; Peter Maslak, MD; Martin S. Tallman, MD

A 47-year-old woman presented for evaluation of pancytopenia. She ...

CTA Community Poll

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs